Description
There is no detailed description, see related
Used in the treatment of
- Y42.0 Adverse effects in therapeutic use, glucocorticoids and synthetic analogues
- E23.2 Diabetes insipidus
- E66 Obesity
- I10 Essential (primary) hypertension
- I15 Secondary hypertension
- I15.0 Renovascular hypertension
- I50.0 Congestive heart failure
- I50.9 Heart failure, unspecified
- K74 Fibrosis and cirrhosis of liver
- K76.6 Portal hypertension
- N00 Acute nephritic syndrome
- N04 Nephrotic syndrome
- N05 Unspecified nephritic syndrome
- N12 Tubulo-interstitial nephritis, not specified as acute or chronic
- N18 Chronic kidney disease
- N18.9 Chronic kidney disease, unspecified
- N25.1 Nephrogenic diabetes insipidus
- N94.3 Premenstrual tension syndrome
- O12.0 Gestational oedema
- O15 Eclampsia
- R18 Ascites
- R35 Polyuria
- R60 Oedema, not elsewhere classified
- R60.9 Oedema, unspecified
- R82.9 Other and unspecified abnormal findings in urine